Public Companies
Irwin Naturals Acquires Kentucky Ketamine Clinic
Serenity is expected to add $3 million in EBITDA to Irwin’s financials.
The post Irwin Naturals Acquires Kentucky Ketamine Clinic appeared first on Green…
Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) continued its expansion spree with its acquisition of Serenity Health LLC, a ketamine clinic in Louisville, Kentucky.
Total consideration will be paid in upfront and deferred consideration. The deal also includes contingent payments based on milestones related to expansion and profitability goals.
The acquisition marks two key milestones in Irwin’s Emergence clinics growth strategy in the mental health industry. First, the acquisition is expected to be immediately accretive by adding an estimated $3 million in projected EBITDA, increasing the company’s annualized EBITDA by double digits. Second, the addition of this clinic further demonstrates Irwin’s ability to attract profitable clinics as part of its goal to establishing the world’s largest network of psychedelic mental health clinics.
The acquisition of Serenity Health brings the total number of clinics under the Irwin Naturals Emergence umbrella either under a definitive agreement, the Braxia letter of intent, or acquired to 22, including existing clinics in Florida, Vermont, New Hampshire, Iowa, and Georgia.
Irwin announced its intent to acquire Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF) last month, though the price tag of that deal is yet to be determined. That move will expand Irwin’s operating footprint in both the U.S. and Canada.
The post Irwin Naturals Acquires Kentucky Ketamine Clinic appeared first on Green Market Report.
ketamine psychedelic cse otc deal braxia scientific braxia irwin naturals-
Law & Regulation6 days ago
FDA to weigh safety, impact of MDMA therapy for PTSD at June meeting
-
Psychedelics1 week ago
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support
-
Psilocybin1 week ago
The Psychedelic Scene in Oaxaca, Mexico
-
Psychedelics1 week ago
MindMed Reports First Quarter 2024 Financial Results and Business Updates
-
Psychedelics1 week ago
Oprah Daily’s Comprehensive Guide to Psychedelics: A Milestone for Industry Acceptance
-
Psychedelics1 week ago
Lophos Pharmaceuticals Corp. Enters Into Letter of Intent to Acquire the Assets of Magicactus.com
-
Psilocybin7 days ago
Oregon authorities give Kaya Holdings license for psilocybin treatment clinic
-
Ketamine1 week ago
Reunion Neuroscience raises $103 million